Ateganosine (THIO, 6-thio-2'-deoxyguanosine), a first-in-class telomere-targeting therapy under development by MAIA ...
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
Riedemann, Chief Executive Officer and Founder of InflaRx , commented: “InflaRx welcomes the granting of izicopan as the INN for INF904. We believe the promising clinical data recently reported in ...
Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Knee Osteoarthritis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering ...
The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...
The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.
Despite granting the FDA enhanced authority to mandate postmarketing studies, revise safety labels, and enforce active surveillance, the FDAAA was not associated with statistically significant ...
Preliminary studies indicate that derivatives of verticillin A can kill certain types of glioma cells. MIT chemists have, for ...
ORLANDO -- Adding four monthly infusions of novel ianalumab helped adults with primary immune thrombocytopenia (ITP) achieve durable disease control in the second-line setting while stopping daily ...
Researchers studied synthetic lethality pathway using Promega NanoBRET(R) TE technology -- Study is the first to characterize uncompetitive binding directly in live cells, illuminating a mechanistic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results